Anna-Karin Olsson

Publikationer

Senaste publikationer

• Identification of the Major Protein Components of Human and Cow Saliva (2023)
• Extended cleavage specificities of human granzymes A and K, two closely related enzymes with conserved but still poorly defined functions in T and NK cell-mediated immunity (2023)
• Neutrophil extracellular traps in the pathology of cancer and other inflammatory diseases (2023)
• Targeting Glioblastoma-Associated Macrophages for Photodynamic Therapy Using AGuIX^®-Design Nanoparticles (2023)
• Quantitative Analysis of the Transcriptome of Two Commonly Used Human Monocytic Cell Lines-THP-1 and Mono Mac 6-Reveals Their Arrest during Early Monocyte/Neutrophil Differentiation (2022)

Alla publikationer

Artiklar

• Identification of the Major Protein Components of Human and Cow Saliva (2023)
• Extended cleavage specificities of human granzymes A and K, two closely related enzymes with conserved but still poorly defined functions in T and NK cell-mediated immunity (2023)
• Neutrophil extracellular traps in the pathology of cancer and other inflammatory diseases (2023)
• Targeting Glioblastoma-Associated Macrophages for Photodynamic Therapy Using AGuIX^®-Design Nanoparticles (2023)
• Quantitative Analysis of the Transcriptome of Two Commonly Used Human Monocytic Cell Lines-THP-1 and Mono Mac 6-Reveals Their Arrest during Early Monocyte/Neutrophil Differentiation (2022)
• Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden (2022)
• Chicken cathepsin G-like - A highly specific serine protease with a peculiar tryptase specificity expressed by chicken thrombocytes (2022)
• The Human Monocyte (2022)
• Quantitative In-Depth Transcriptome Analysis Implicates Peritoneal Macrophages as Important Players in the Complement and Coagulation Systems (2022)
• Mast cell tryptase potentiates neutrophil extracellular trap formation (2022)
• Extended cleavage specificity of a Chinese alligator granzyme B homologue, a strict Glu-ase in contrast to the mammalian Asp-ases (2022)
• Inflammation and neutrophil extracellular traps in cerebral cavernous malformation (vol 79, 206, 2022) (2022)
• Inflammation and neutrophil extracellular traps in cerebral cavernous malformation (2022)
• Platelet-Derived PDGFB Promotes Recruitment of Cancer-Associated Fibroblasts, Deposition of Extracellular Matrix and Tgf beta Signaling in the Tumor Microenvironment (2022)
• Mast Cells and Basophils in the Defense against Ectoparasites (2021)
• Illustrated State-of-the-Art Capsules of the ISTH 2020 Congress (2020)
• Specific targeting of PDGFR beta in the stroma inhibits growth and angiogenesis in tumors with high PDGF-BB expression (2020)
• Platelet-Specific PDGFB Ablation Impairs Tumor Vessel Integrity and Promotes Metastasis (2020)
• TANK-binding kinase 1 is a mediator of platelet-induced EMT in mammary carcinoma cells (2019)
• Platelets, NETs and cancer (2018)
• Trametinib prevents mesothelial-mesenchymal transition and ameliorates abdominal adhesion formation (2018)
• Consensus guidelines for the use and interpretation of angiogenesis assays (2018)
• The pro-inflammatory role of platelets in cancer (2018)
• Pharmacological targeting of peptidylarginine deiminase 4 prevents cancer-associated kidney injury in mice. (2017)
• Development of a novel therapeutic vaccine carrier that sustains high antibody titers against several targets simultaneously (2017)
• Tumor-induced neutrophil extracellular traps-drivers of systemic inflammation and vascular dysfunction (2016)
• Immunity Gone Astray - NETs in Cancer (2016)
• Tumor-Induced NETosis as a Risk Factor for Metastasis and Organ Failure (2016)
• NETosis in Cancer - Platelet-Neutrophil Crosstalk Promotes Tumor-Associated Pathology (2016)
• Targeting Serglycin Prevents Metastasis in Murine Mammary Carcinoma (2016)
• Ras and TGF-beta signaling enhance cancer progression by promoting the Delta Np63 transcriptional program (2016)
• Tumor-Induced Local and Systemic Impact on Blood Vessel Function (2015)
• Neutrophil Extracellular Traps Accumulate in Peripheral Blood Vessels and Compromise Organ Function in Tumor-Bearing Animals (2015)
• Vaccines targeting self-antigens (2015)
• CCL2 and CCL5 Are Novel Therapeutic Targets for Estrogen-Dependent Breast Cancer (2015)
• Reprogramming during epithelial to mesenchymal transition under the control of TGF beta (2015)
• Vaccination approach to anti-angiogenic treatment of cancer (2015)
• Pleiotrophin promotes vascular abnormalization in gliomas and correlates with poor survival in patients with astrocytomas. (2015)
• Therapeutic vaccination against fibronectin ED-A attenuates progression of metastatic breast cancer. (2014)
• Therapeutic vaccination targeting the tumour vasculature (2014)
• HRG regulates tumor progression, epithelial to mesenchymal transition and metastasis via platelet-induced signaling in the pre-tumorigenic microenvironment (2013)
• Extracellular RNA Liberates Tumor Necrosis Factor-alpha to Promote Tumor Cell Trafficking and Progression (2013)
• Inflammation induced by mmp-9 enhances tumor regression of experimental breast cancer (2013)
• Prediction of Preeclampsia by Combining Serum Histidine-Rich Glycoprotein and Uterine Artery Doppler (2012)
• The non-toxic and biodegradable adjuvant Montanide ISA 720/CpG can replace Freund's in a cancer vaccine targeting ED-B-a prerequisite for clinical development (2012)
• Development of a therapeutic vaccine targeting blood vessels in primary tumors and metastases (2012)
• Enhanced Platelet Activation Mediates the Accelerated Angiogenic Switch in Mice Lacking Histidine-Rich Glycoprotein (2011)
• Vaccination against the extra domain-B of fibronectin as a novel tumor therapy (2010)
• Fibrinogen and histidine-rich glycoprotein in early-onset preeclampsia (2010)
• The internally truncated LRP5 receptor presents a therapeutic target in breast cancer (2009)
• Histidine-rich glycoprotein can prevent development of mouse experimental glioblastoma (2009)
• Regulation of histidine-rich glycoprotein (HRG) function via plasmin-mediated proteolytic cleavage (2009)
• Identification of potent biodegradable adjuvants that efficiently break self-tolerance (2009)
• Activated platelets provide a functional microenvironment for the antiangiogenic fragment of histidine-rich glycoprotein (2009)
• alphaB-crystallin promotes tumor angiogenesis by increasing vascular survival during tube morphogenesis (2008)
• Histidine-rich glycoprotein protects from systemic Candida infection (2008)
• Histidine-rich glycoprotein exerts antibacterial activity (2007)
• Minimal active domain and mechanism of action of the angiogenesis inhibitor histidine-rich glycoprotein (2006)
• Signal transduction in endothelial cells by the angiogenesis inhibitor histidine-rich glycoprotein targets focal adhesions (2006)
• VEGF receptor signalling (2006)
• The Anti-angiogenic His/Pro-rich Fragment of Histidine-rich Glycoprotein Binds to Endothelial Cell Heparan Sulfate in a Zn2+-dependent Manner (2006)
• The minimal active domain of endostatin is a heparin-binding motif that mediates inhibition of tumor vascularization (2004)
• A fragment of histidine-rich glycoprotein is a potent inhibitor of tumor vascularization (2004)
• Activation of Ras, Raf-1 and protein kinase C in differentiating human neuroblastoma cells after treatment with phorbolester and NGF (2001)
• Global gene expression analysis of distant organ vasculature in mice with cancer
• AAV-mouse DNase I sustains long-term DNase I expression in vivo and suppresses breast cancer metastasis
• Regulation of tumor-associated macrophage infiltration, VEGF and MMP production, by the angiogenesis inhibitor histidine-rich glycoprotein.

Patent

• Histidine-rich glycoprotein (2002)